Search - tctmd.com

Displaying 1 - 20 of 33

Sort: Relevancy | Date

$Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis$

News Daily News

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

Todd Neale

August 13, 2025

Presentation TCT India 2025

Coronary Sinus Reducer

Presenter: Ajar Kochar

July 26, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2025

Shelley Wood

January 31, 2025

News Daily News

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Michael O'Riordan

January 03, 2025

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

Presentation TCT 2024

TCT 102: First-in-Man Experience With the Self-Expandable A-Flux Coronary Sinus Reducer for Treating Symptomatic Ischemic Heart Disease

Presenter: Francesco Giannini

October 30, 2024

Presentation TCT 2024

TCT 673: Coronary Sinus Reducer for the Treatment of Angina With Non-Obstructive Coronary Artery Disease (ANOCA)

Presenter: Maayan Konigstein

October 27, 2024

$TCT 402: The Efficacy of Coronary Sinus Reducer in Patients With Refractory Angina Caused by Chronic Total Occlusion (CTO)$

Presentation TCT 2024

TCT 402: The Efficacy of Coronary Sinus Reducer in Patients With Refractory Angina Caused by Chronic Total Occlusion (CTO)

Presenter: Maayan Konigstein

October 27, 2024

Presentation TCT 2024

TCT 1463: Improvement in Coronary Microcirculatory Function With A-FLUX Next-Generation Coronary Sinus Reducer

Presenter: Manel Sabate

October 27, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Conference News TCT 2023

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Yael L. Maxwell

November 06, 2023

Presentation TCT 2023

Coronary Sinus Reducer Improves Angina and Coronary Flow Reserve in Patients With Coronary Microvascular Dysfunction

Presenter: David Tryon

October 25, 2023

Presentation TCT 2023

Discussion & Closing Comments

Presenter: Timothy Henry

October 24, 2023

Presentation TCT 2023

The Future of Clinical Data for The Reducer

Presenter: Megha Prasad

October 24, 2023

Presentation TCT 2023

The Coronary Sinus Reducer

Presenter: Stefan Verheye

October 24, 2023

Presentation TCT 2023

Patients – Where are They?

Presenter: Timothy Henry

October 24, 2023

Presentation TCT 2023

Angina – The Scope of the Challenge

Presenter: Allen Jeremias

October 24, 2023

Advertisement

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

Coronary Sinus Reducer

TCTMD’s Top 10 Most Popular Stories for January 2025

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

November 2024 Dispatch for the CV Team

TCT 102: First-in-Man Experience With the Self-Expandable A-Flux Coronary Sinus Reducer for Treating Symptomatic Ischemic Heart Disease

TCT 673: Coronary Sinus Reducer for the Treatment of Angina With Non-Obstructive Coronary Artery Disease (ANOCA)

TCT 402: The Efficacy of Coronary Sinus Reducer in Patients With Refractory Angina Caused by Chronic Total Occlusion (CTO)

TCT 1463: Improvement in Coronary Microcirculatory Function With A-FLUX Next-Generation Coronary Sinus Reducer

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

What’s Going to Be Hot at ACC 2024

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Coronary Sinus Reducer Improves Angina and Coronary Flow Reserve in Patients With Coronary Microvascular Dysfunction

Discussion & Closing Comments

The Future of Clinical Data for The Reducer

The Coronary Sinus Reducer

Patients – Where are They?

Angina – The Scope of the Challenge

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content